Ligand Pharmaceuticals (LGND) Current Taxes (2019 - 2025)
Historic Current Taxes for Ligand Pharmaceuticals (LGND) over the last 6 years, with Q3 2025 value amounting to $1.3 million.
- Ligand Pharmaceuticals' Current Taxes fell 3908.92% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 3908.92%. This contributed to the annual value of $1.2 million for FY2024, which is N/A changed from last year.
- Ligand Pharmaceuticals' Current Taxes amounted to $1.3 million in Q3 2025, which was down 3908.92% from $305000.0 recorded in Q2 2025.
- In the past 5 years, Ligand Pharmaceuticals' Current Taxes ranged from a high of $11.4 million in Q2 2023 and a low of $305000.0 during Q2 2025
- Over the past 4 years, Ligand Pharmaceuticals' median Current Taxes value was $1.9 million (recorded in 2024), while the average stood at $3.5 million.
- Data for Ligand Pharmaceuticals' Current Taxes shows a peak YoY increase of 20108.41% (in 2023) and a maximum YoY decrease of 8759.15% (in 2023) over the last 5 years.
- Ligand Pharmaceuticals' Current Taxes (Quarter) stood at $9.7 million in 2022, then crashed by 87.59% to $1.2 million in 2023, then decreased by 0.42% to $1.2 million in 2024, then grew by 7.09% to $1.3 million in 2025.
- Its Current Taxes was $1.3 million in Q3 2025, compared to $305000.0 in Q2 2025 and $1.8 million in Q1 2025.